Riphah International University   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Islamabad Pakistan (2002)

Organization Overview

First Clinical Trial
2020
NCT04559906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

IIMC, Riphah International University, Pakistan | IIMC-T, Riphah International University, Rawalpindi | Riphah college of rehabilitation and allied health sciences - Rawalpindi | Riphah International University | Riphah International University Islamabad | Riphah International University, Islamabad | Riphah International University, Islamabad. | RIPHAH INTERNATIONAL UNIVERSITY,ISLAMABAD,PAKISTAN | Riphah international university Lahore | Riphah International University,Lahore | Riphah International University, Lahore | Riphah international university lahore campus | Riphah international university.pakistan | Riphah International University , QIE, Campus | Riphah International University, Rawalpindi | Riphah international universty | riphah internation university | Riphah University Lahore | RIU lahore

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Myofascial Pain Syndromes (Phase 2)

Neck Pain (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 12